AgeX Therapeutics, Inc. (AGE)

Stock-Based Compensation

$3.13M

TTM · Period ending: · USD

AGE logo

AGE Stock-Based Compensation

Latest reported$3.13M
AGE TTM Stock-Based Comp ($1.47M → $3.13M)
High-resolution chart · PNG

AGE stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period endingStock-Based Compensation (USD)
3,127,000
2,966,000
2,845,000
4,844,000
4,896,000
4,029,000
3,126,000
1,630,000
619,000
631,000
648,000
259,000
428,000
591,000
760,000
909,000
972,000
1,060,000
999,000
918,000
878,000
851,000
933,000
1,171,000
1,430,000
1,686,000
1,907,000
2,284,000
2,003,000
1,719,000
1,473,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.